Trials Sponsors Conditions Drugs Pricing

Conditions

Decreased Clitoral Sensitivity

Keywords

non-ablativeEr:YAG laserclitoral atrophyhyperstackingsexual healthorgasmclitoris

Outcome Measures

Primary Outcomes (1)

Change of bothersome symptoms (decreased intensity of clitoral/vaginal response, decreased time of good sexual response, decreased orgasm sensation)
Evaluation of clitoral sensitivity change was performed 2 months after the last treatment session. Patients answered a five-point Likert scale (from 0 to 4) questionnaire.
Change from Baseline at 2 months after last intervention

Secondary Outcomes (2)

Patient satisfaction with 5-point Likert scale
Each visit included recording of any adverse effect. Patients were instructed to report and adverse effect that may have occured during the whole duration of the study.
Recording of frequency and severity of adverse effects related to laser treatment
From Baseline to 2 months after last intervention

Study Arms (1)

Active therapy with non-ablative Er:YAG laser

EXPERIMENTAL

Patients underwent three laser sessions with non-ablative SMOOTH Er:YAG laser, with 20 days interval between sessions

Device: Active therapy with non-ablative Er:YAG laser

Interventions

Active therapy with non-ablative Er:YAG laserDevice

three intravaginal and vulvar/clitoral treatments within 60 days

Active therapy with non-ablative Er:YAG laser

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

above 18 years
sexually active at least once per month

You may not qualify if:

Sponsors & Collaborators

Espacio Gaspar Clinic
Otherlead

Study Sites (1)

Uroclinica

Mendoza, Argentina

MeSH Terms

Conditions

Orgasm

Condition Hierarchy (Ancestors)

Sexual BehaviorBehavior

Study Officials

Adrian Gaspar, MD
Espacio Gaspar Clinic
PRINCIPAL INVESTIGATOR

Enrollment

133 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

August 26, 2025

First Posted

September 3, 2025

Study Start

March 1, 2022

Actual (reported)

Clitoral Sensitivity Enhancement With Laser

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Active therapy with non-ablative Er:YAG laser

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Active therapy with non-ablative Er:YAG laser

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations